Effects of slow release misoprostol on uterine contractility in early pregnancy

Human Reproduction

Volumn 20, Issue 9, 2005, Pages 2648-2652

  Fiala, C ^a,b   Aronsson, A ^a   Stephansson, O ^a   Gemzell Danielsson, Kristina ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Gynmed Ambulatorium   (Austria)

Author keywords

Misoprostol; Pregnancy; Slow release; Sublingual administration; Uterine contractility

Indexed keywords

MISOPROSTOL;

ADULT; ARTICLE; CLINICAL TRIAL; COMPUTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CURETTAGE; DOSE RESPONSE; DRUG ACTIVITY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; INDUCED ABORTION; INTRAUTERINE PRESSURE; NAUSEA; PILOT STUDY; PRESSURE MEASUREMENT; PRESSURE TRANSDUCER; RANDOMIZED CONTROLLED TRIAL; SLOW RELEASE FORMULATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UTERUS BLEEDING; UTERUS CONTRACTILITY; VOMITING;

EID: 24044488285     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/dei102     Document Type: Article

References (19)

1. Aronsson A, Bygdeman M and Gemzell-Danielsson K (2004a) Effects of misoprostol on uterine contractility following different routes of administration. Hum Reprod 19,81-84.
2. Aronsson A, Helstrom L and Gemzell-Danielsson K (2004b) Sublingual compared with oral misoprostol for cervical dilatation prior to vacuum aspiration: A randomized comparison. Contraception 69,165-169.
3. Ashok PW, Penney GC, Flett GMM and Templeton A (1998) An effective regimen for early medical abortion: A report of 2000 consecutive cases. Hum Reprod 13,2962-2965.
4. Aubeny E (1997) Evolution since 1989 in France of Abortion by mifepristone (RU 486) associated with an analogue of prostaglandin [Evolution depuis 1989, en France, des interruptions volontaires de grossesse par mifépristone (RU 486) associée à un analogue de prostaglandine]. Contracept Fertil Sex 25,777-781.
5. Bygdeman M, Christensen NJ, Dimov V and Green K (1984) Termination of pregnancy by a slow release device containing 16, 16-dimethyl-trans-delta 2 PGE1 methyl ester. Asia Oceania J Obstet Gynaecol 10,359-365.
6. Cameron IT and Baird DT (1986) A controlled release form of 16,16-dimethyl-trans-delta 2-PGE, methyl ester for early abortion. Contraception 33,121-125.
7. Caldeyro-Barcia R and Poserro JJ (1959) Oxytocin and contractility of the human pregnant uterus. Am NY Acad Sci 75,813-830.
8. Chen D, Tsay R-J, Lin H-I, Chen H, Chao SC and Ku H (2000) Stabilization and sustained-release effect of misoprostol with metharylate copolymer. Int J Pharm 203,141-148.
9. El-Refaey H, Rajasekar D, Abdalla M, Calder L and Templeton A (1995) Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. New Engl J Med 332,983-987.
10. Gemzell Danielsson K, Marions L, Rodriguez A, Spur BW, Wong PY and Bygdeman M (1999) Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol 93,275-280.
11. Hamoda H, Ashok PW, Flett GM and Templeton A (2004) A randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical priming before first-trimester surgical abortion. Am J Obstet Gynecol 190,55-59.
12. Ho PC, Ngai SW, Liu KL, Wong GC and Lee SW (1997) Vaginal misoprostol compared with oral misoprostol in termination of second trimester pregnancy. Obstet Gynecol 90,735-738.
13. Norman JE, Thong KJ and Baird DT (1991) Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet 16,338(8777),1233-1236.
14. Tang OS, Schweer H, Seyberth HW, Lee SW and Ho PC (2002) Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 17,332-336.
15. Tang OS, Chan CC, Ng EH, Lee SW and Ho PC (2003) A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation. Hum Reprod 18,2315-2318.
16. Tang OS, Lau WN, Chan CC and Ho PC (2004) A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy. Br J Obstet Gynaecol 111,1001-1005.
17. von Hertzen H, Honkanen H, Piaggio G, Bartfai G, Erdenetungalag R, Gemzell-Danielsson K, Gopalan S, Horga M, Jerve F, Mittal S et al. (2003) WHO Research Group on Post-Ovulatory Methods for Fertility Regulation.WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy. Br J Obstet Gynaecol 110,808-818.
18. Winikoff B (1995) Acceptability of medical abortion in early pregnancy. Fam Plann Perspect 185,142-148.
19. Zieman M, Fong SK, Benowitz NL, Banskter D and Darney PD (1997) Absorption kinetics of misoprostol with oral or vagina administration. Obstet Gynecol 90,88-92.